Anti-cd45-based conditioning methods and uses thereof in conjunction with gene-edited cell-based therapies
US-2024158528-A1 · May 16, 2024 · US
This page is not indexed by search engines while we improve data quality.
Thomas Keisha patents
Thomas Keisha is listed as an inventor on 8 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Thomas Keisha |
| Total patents | 8 |
| First publication | Apr 23, 2020 |
| Latest publication | May 16, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Anti-CD45-based conditioning methods and uses thereof in conjunction with gene-edited cell-based therapies
US-11912780-B2 · Feb 27, 2024 · US
Combination therapy for treatment of a hematological disease
US-2023132400-A9 · Apr 27, 2023 · US
Anti-cd45-based lymphodepletion methods and uses thereof in conjction with act-based cancer therapies
US-2021198359-A1 · Jul 1, 2021 · US
Methods for cancer treatment using a radiolabeled anti-cd45 immunoglobulin and adoptive cell therapies
US-2020308280-A1 · Oct 1, 2020 · US
Combination therapy for treatment of a hematological disease
US-2020283539-A1 · Sep 10, 2020 · US
Anti-cd45-based conditioning methods and uses thereof in conjunction with gene-edited cell-based therapies
US-2020255520-A1 · Aug 13, 2020 · US
Treatments for a hematological malignancy
US-2020121815-A1 · Apr 23, 2020 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Actinium Pharmaceuticals Inc | 8 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 8 |
| A61K51/1096 | 8 |
| A61K51/1027 | 8 |
| A61K2039/505 | 8 |
| A61K40/416 | 5 |